Sensitive assay for midazolam and its metabolite 1′-hydroxymidazolam in human plasma by capillary high-performance liquid chromatography
- 15 June 1998
- journal article
- Published by Elsevier in Journal of Chromatography B: Biomedical Sciences and Applications
- Vol. 710 (1-2), 165-171
- https://doi.org/10.1016/s0378-4347(98)00137-6
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Evidence for involvement of human CYP3A in the 3‐hydroxylation of quinineBritish Journal of Clinical Pharmacology, 1997
- Use of Probe Drugs as Predictors of Drug Metabolism in HumansThe Journal of Clinical Pharmacology, 1997
- Oral first-pass elimination of midazolam involves both gastrointestinal and hepatic CYP3A-mediated metabolism*Clinical Pharmacology & Therapeutics, 1996
- Regioselective biotransformation of midazolam by members of the human cytochrome P450 3A (CYP3A) subfamilyBiochemical Pharmacology, 1994
- Pharmacokinetic-pharmacodynamic modeling of the central nervous system effects of midazolam and its main metabolite α-hydroxymidazolam in healthy volunteersClinical Pharmacology & Therapeutics, 1992
- Simultaneous determination of midazolam and its three hydroxy metabolites in human plasma by electron-capture gas chromatography without derivatizationJournal of Chromatography B: Biomedical Sciences and Applications, 1989
- MidazolamAnesthesiology, 1985
- Midazolam A Review of its Pharmacological Properties and Therapeutic UseDrugs, 1984
- Pharmacokinetics and bioavailability of midazolam in man.British Journal of Clinical Pharmacology, 1983
- Midazolam determination by gas chromatography, liquid chromatography and gas chromatography—mass spectrometryJournal of Chromatography B: Biomedical Sciences and Applications, 1982